AVI BioPharma, Inc. (AVII.O)

AVII.O on Consolidated Issue listed on NASDAQ Global Market

1.45USD
18 Dec 2009
Price Change (% chg)

$-0.01 (-0.68%)
Prev Close
$1.46
Open
$1.47
Day's High
$1.51
Day's Low
$1.45
Volume
1,485,078
Avg. Vol
1,041,839
52-wk High
$2.73
52-wk Low
$0.46

AVII.O

Chart for AVII.O

About

AVI BioPharma, Inc. (AVI) is a biopharmaceutical company specializing in the discovery and development of ribonucleic acid (RNA)-based drugs targeting a range of diseases. The Company has developed and optimized derivatives of its antisense chemistry (phosphorodiamidate morpholino oligomers (PMOs)) that can be designed to target... (more)

Overall

Beta: 1.71
Market Cap (Mil.): $161.24
Shares Outstanding (Mil.): 110.44
Annual Dividend: 0.00
Yield (%): NA

Financials

  AVII.O Industry Sector
P/E (TTM): -- 12.05 4.64
EPS (TTM): 17.51 -- --
ROI: -145.81 1.33 2.79
ROE: -166.44 2.17 3.51
view overview for:

HEADLINE STOCKS-Some U.S. stocks on the move on Oct. 5

(Updates to after the open, adds Caterpillar, Seattle Genetics, Manitowoc, MKS Instruments, Frontier Financial Peregrine, Finisar)

05 Oct 2009

UPDATE 1-AVI BioPharma gets funding to develop Junin virus drug

Oct 5 (Reuters) - AVI BioPharma Inc said it received expanded contract funding of about $11.5 million from the U.S. Department of Defense (DoD) to develop its drug candidate for the treatment of Junin virus infection, sending its shares up about 28 percent before the bell.

05 Oct 2009

HEADLINE STOCKS-Some U.S. stocks to watch on Oct. 5

NEW YORK, Oct 5 (Reuters) - Some U.S. stocks to watch on Monday:

05 Oct 2009

Successful study may boost Avi BioPharma-Barron's

NEW YORK, Oct 4 (Reuters) - If Avi BioPharma's drug for Duchenne muscular dystrophy proves successful, shares of this biotech are likely to surge, Barron's said on Sunday.

04 Oct 2009

HEADLINE STOCKS-Some U.S. stocks on the move on Aug. 10

(Updates to afternoon trading, adds SL Green, RIM, Lloyds, Freddie Mac, Priceline, Barnes & Noble, DryShips, Stillwater, EW Scripps and WNS)

10 Aug 2009

HEADLINE STOCKS-Some U.S. stocks on the move on Aug 10

(Updates to after the open, adds Eli Lilly, Boeing, Allied Capital, Wal-Mart, Colonial/BB&T, Marshall & Ilsley, Houston Wire, Maguire, AVI BioPharma, Echelon/Duke)

10 Aug 2009

BEFORE THE BELL-AVI BioPharma shrs down after Q2 loss

NEW YORK, Aug 10 (Reuters) - Shares of AVI BioPharma Inc fell 4.6 percent to $2.29 in premarket trading on Monday after it reported a wider quarterly loss.

10 Aug 2009

UPDATE 1-AVI BioPharma Q2 loss widens, shares fall

Aug 10 (Reuters) - AVI BioPharma Inc posted a wider quarterly loss, hurt by a non-cash expense, sending its shares down nearly 13 percent in premarket trade.

10 Aug 2009

Shares of flu drugmakers rise on latest WHO stats

BANGALORE (Reuters) - Shares of companies that make vaccines and drugs for flu rose on Monday after the World Health Organization said more than 20 countries and overseas territories confirmed their first cases of the H1N1 swine flu virus.

27 Jul 2009

Shares of flu drugmakers rise on latest WHO stats

BANGALORE (Reuters) - Shares of companies that make vaccines and drugs for flu rose on Monday after the World Health Organization said more than 20 countries and overseas territories confirmed their first cases of the H1N1 swine flu virus.

27 Jul 2009

Competitors

  Price Change
Merck & Co., Inc. (MRK.N) $37.40 +0.12
ISIS Pharmaceuticals, Inc. (ISIS.OQ) $9.94 -0.01

  Earnings  vs    Estimates

view overview for: